Common interests unite radiologists and oncologists
This special supplement to Diagnostic Imaging and Oncology News International focuses on selected reports about CT, MRI, and PET from the 2004 meetings of the Radiological Society of North America and the American Society for Therapeutic Radiology and Oncology.
This special supplement to Diagnostic Imaging and Oncology News International focuses on selected reports about CT, MRI, and PET from the 2004 meetings of the Radiological Society of North America and the American Society for Therapeutic Radiology and Oncology.
Expert commentary puts these techniques into the context of daily practice in clinical oncology. Discussion shows the significant ways in which MRI, CT, and PET have evolved in recent years and how they complement each other, not only in diagnosis but also in staging tumors and targeting treatments such as focused ultrasound, ablation, and chemotherapy.
-Jane Lowers
Special Projects Editor
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
